Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
David P. Perry Insider Profile
11 Followers
David P. Perry, President & CEO, Director at Anacor Pharmaceuticals, holds 361.31K shares in Anacor Pharmaceuticals (Ticker: ~ANAC), holds ― shares in Evelo Biosciences (Ticker: EVLO), holds 19.40M shares in Better Therapeutics, Inc. (Ticker: BTTX).
David P. Perry Anacor Pharmaceuticals (~ANAC)President & CEO, Director
Anacor Pharmaceuticals (~ANAC)
President & CEO, Director
Ranked #94,507 out of 98,624 Corporate Insiders
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-101.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that David P. Perry holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Sep 19, 2022 - Sep 19, 2023
Return:-77.20%
The most profitable trade made by David P. Perry
David P. Perry's Trading History
Anacor Pharmaceuticals
Mar 06, 2014
―
Uninformative Sell
303.30K
$35.80M
Evelo Biosciences
―
Director
―
―
Better Therapeutics, Inc.
Feb 13, 2024
EC, Director, Ten Percent Owner
Uninformative Buy
159.58K
$213.38K
List of latest transactions for each holding click on a transaction to see David P. Perry's performance on stock
You May Also Like
David P. Perry insider profile FAQ
What is the percentage of profitable transactions made by David P. Perry?
The percentage of profitable transactions made by David P. Perry is 0%.
What is the average return per transaction made by David P. Perry?
The average return per transaction made by David P. Perry is -101.50%.
What stocks does David P. Perry hold?
David P. Perry holds: ~ANAC, EVLO, BTTX stocks.
What was David P. Perry’s latest transaction?
David P. Perry latest transaction was an Uninformative Sell of $303.30K.
What was David P. Perry's most profitable transaction?
David P. Perry’s most profitable transaction was an Informative Buy of BTTX stock on September 19, 2022. The return on the trade was -77.20%.
What is David P. Perry's role in Anacor Pharmaceuticals?
David P. Perry's role in Anacor Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.